Joseph F. Bower

HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.

R. Wyatt, Yuxing Li, T. Ross, 2006, Vaccine.

C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences.

T. Ross, Kelly Sanders, Joseph F. Bower, 2005, Current HIV research.

Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.

T. Ross, K. Young, T. Green, 2004, AIDS research and human retroviruses.

A minimum CR2 binding domain of C3d enhances immunity following vaccination.

T. Ross, Joseph F. Bower, 2006, Advances in experimental medicine and biology.

Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3d

J. Sodroski, T. Ross, Xinzhen Yang, 2004, Journal of Virology.

Cutting Edge: C3d Functions as a Molecular Adjuvant in the Absence of CD21/35 Expression 1

D. Karp, K. Haas, J. Oliver, 2004, The Journal of Immunology.

DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.

T. Ross, Joseph F Bower, T. Green, 2004, Virology.